Literature DB >> 16257426

High prevalence of hepatitis E antibodies in pregnant Egyptian women.

Sonia K Stoszek1, Mohamed Abdel-Hamid, Doa'a A Saleh, Sherif El Kafrawy, Shaker Narooz, Yousry Hawash, Fatma M Shebl, Mai El Daly, Ahmed Said, Enas Kassem, Nabiel Mikhail, Ronald E Engle, Mohamed Sayed, Soraya Sharaf, Alan D Fix, Suzanne U Emerson, Robert H Purcell, G Thomas Strickland.   

Abstract

The epidemiology of hepatitis E virus (HEV), an enterically-transmitted cause of acute viral hepatitis (AVH), is not fully understood. During outbreaks on the Indian subcontinent and elsewhere, HEV causes severe AVH with mortality rates around 20% during pregnancy. In Egypt, where prevalence of HEV antibodies (anti-HEV) in rural communities is very high, severe HEV-caused AVH in pregnant women has not been reported. This study examined a cohort of 2,428 pregnant women in the Nile Delta to assess prevalence of, and risk factors for, anti-HEV and correlated these with history of liver disease. Anti-HEV prevalence was 84.3%. Several risk factors associated with anti-HEV included older age, many siblings, not using soap to wash produce and frequent contact with cats. History of jaundice and liver disease was rare and not increased in those having anti-HEV. Our results confirm Egypt's high HEV endemicity and show that almost all women of childbearing age in these communities had prior HEV exposures without a history of liver disease. Reasons for the lack of clinical hepatitis remain unclear but could be the result of early childhood HEV exposures, producing long-lasting immunity and/or modify subsequent responses to exposure. Alternatively, the predominant HEV strain(s) in Egypt are less virulent than those in South Asia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16257426     DOI: 10.1016/j.trstmh.2004.12.005

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  65 in total

1.  Gene expression profiles of T cells from hepatitis E virus infected patients in acute and resolving phase.

Authors:  Nirupma TrehanPati; Sukriti Sukriti; Robert Geffers; Syed Hissar; Peggy Riese; Tanja Toepfer; Carlos A Guzman; Shiv Kumar Sarin
Journal:  J Clin Immunol       Date:  2011-02-03       Impact factor: 8.317

2.  A preliminary cost-effectiveness analysis of hepatitis E vaccination among pregnant women in epidemic regions.

Authors:  Yueyuan Zhao; Xuefeng Zhang; Fengcai Zhu; Hui Jin; Bei Wang
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

Review 3.  Involvement of Egyptian Foods in Foodborne Viral Illnesses: The Burden on Public Health and Related Environmental Risk Factors: An Overview.

Authors:  Hamada Aboubakr; Sagar Goyal
Journal:  Food Environ Virol       Date:  2019-09-27       Impact factor: 2.778

4.  Hepatitis E: Epidemiology and prevention.

Authors:  Eyasu H Teshale; Dale J Hu
Journal:  World J Hepatol       Date:  2011-12-27

5.  Hepatitis E Virus.

Authors:  Georg Pauli; Martin Aepfelbacher; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Barbara Gärtner; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Uwe Schlenkrich; Volkmar Schottstedt; Rainer Seitz; Johanna Strobel; Hannelore Willkommen; Sally A Baylis
Journal:  Transfus Med Hemother       Date:  2015-06-01       Impact factor: 3.747

6.  The Enigma of Hepatitis E Virus.

Authors:  Liza Bronner Murrison; Kenneth E Sherman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-08

Review 7.  Hepatitis E and pregnancy: understanding the pathogenesis.

Authors:  Udayakumar Navaneethan; Mayar Al Mohajer; Mohamed T Shata
Journal:  Liver Int       Date:  2008-07-25       Impact factor: 5.828

8.  Virulent strain of hepatitis E virus genotype 3, Japan.

Authors:  Kazuaki Takahashi; Hiroaki Okamoto; Natsumi Abe; Manri Kawakami; Hiroyuki Matsuda; Satoshi Mochida; Hiroshi Sakugawa; Yoshiki Suginoshita; Seishiro Watanabe; Kazuhide Yamamoto; Yuzo Miyakawa; Shunji Mishiro
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

9.  Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas.

Authors:  Mélanie Caron; Mirdad Kazanji
Journal:  Virol J       Date:  2008-12-22       Impact factor: 4.099

10.  Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana.

Authors:  Andrew A Adjei; Yao Tettey; John T Aviyase; Clement Adu-Gyamfi; Samuel Obed; Julius A A Mingle; Patrick F Ayeh-Kumi; Theophilus K Adiku
Journal:  Virol J       Date:  2009-07-20       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.